News und Analysen

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for

Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its fiscal third quarter ended October 31, 2020.

Agilent Technologies Inc. (NYSE: A) today announced the launch of the Biomarker Pathologist Training Program, a global initiative created to empower pathologists to score biomarkers accurately and

Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.48 billion for the fourth quarter ended Oct. 31, 2020, up 8% year over year (core⁽¹⁾ growth of 6%).

On a GAAP basis

Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation and software to enable customers

Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 BASIS study of marstacimab (PF-06741086), an anti-tissue factor pathway inhibitor (anti-TFPI) being

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA

The student team of Alexander Kondziolka and Jonathon Thierer from The Wharton School of the University of Pennsylvania has won the $40,000 First Place prize in the Humana-Mays Healthcare Analytics

Pfizer Inc. (NYSE:PFE) today announced results from the Phase 3 CROWN trial of LORBRENA^® (lorlatinib, available in Europe under the brand name LORVIQUA^®) versus XALKORI^® (crizotinib) in people with

Agilent Technologies, Inc. (NYSE: A) today announced that its board of directors has increased the company’s quarterly dividend to 19.4 cents per share of common stock. The dividend reflects an 8%

Additional access to patient-focused primary care is coming to Clark County, Washington, thanks to Vancouver Clinic and Humana (NYSE: HUM), one of the nation’s leading health and well-being

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

Piper Sandler Annual

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine

Veeva-Systeme (NYSE: VEEV) kündigte heute Veeva Link für 11 neue Behandlungsbereiche an, einschließlich bakterieller Infektionen, Kardiologie, Dermatologie, Endokrinologie, Gastroenterologie

Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Bristol Myers Squibb (NYSE: BMY) Veeva Vault PromoMats einführt, um schnelle, konforme Inhalte über alle digitalen Kanäle zu liefern und so die

Medicare beneficiaries in Benton, Walla Walla, and Franklin counties will now have more Medicare Advantage health plan coverage options during the 2021 Medicare Advantage and Prescription Drug Plan

Bristol Myers Squibb (NYSE:BMY) announced today that it has successfully completed its acquisition of MyoKardia, Inc. in an all cash transaction for approximately $13.1 billion. With the completion

Agilent Technologies Inc. (NYSE: A) today announced professors Carl H. June, MD, and Michael Milone, MD, Ph.D., as recipients of an Agilent Thought Leader Award. Both scientists are being

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a Virtual Life Science Event for the investment community on

Veeva Systems (NYSE: VEEV) today announced Veeva Link for 11 new therapeutic areas, including bacterial infections, cardiology, dermatology, endocrinology, gastroenterology, hepatology, nephrology

Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (NYSE: BMY) is adopting Veeva Vault PromoMats to deliver fast, compliant content across all digital channels to meet their

Veeva Systems (NYSE: VEEV) today announced Veeva Link for 11 new therapeutic areas, including bacterial infections, cardiology, dermatology, endocrinology, gastroenterology, hepatology, nephrology

Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (NYSE: BMY) is adopting Veeva Vault PromoMats to deliver fast, compliant content across all digital channels to meet their

Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc.

Pfizer Chairman and Chief